Ha Tay Pharmaceutical JSC (HNX:DHT)

Ha Tay Pharmaceutical JSC Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,171,837	7,822,325	1,893,826	1,027,245	1,188,329	1,126,008
Market Cap Growth	221.93%	313.04%	84.36%	-13.56%	5.54%	9.67%
Enterprise Value	7,396,356	8,001,132	2,176,376	1,106,314	1,073,555	1,287,133
Last Close Price	87100.00	95000.00	22370.14	13512.40	14889.78	17636.11
PE Ratio	98.33	108.99	22.27	10.79	17.49	12.23
PS Ratio	3.32	3.75	0.95	0.56	0.74	0.56
PB Ratio	6.56	7.40	1.78	1.29	1.58	3.22
P/TBV Ratio	6.75	7.61	1.83	1.33	1.63	3.47
P/FCF Ratio	-	-	-	-	-	205.99
P/OCF Ratio	74.53	279.78	6.99	-	-	11.92
EV/Sales Ratio	3.43	3.84	1.09	0.60	0.67	0.64
EV/EBITDA Ratio	71.31	82.49	18.71	9.23	13.64	10.49
EV/EBIT Ratio	91.72	104.57	21.94	10.80	17.30	11.76
EV/FCF Ratio	-398.79	-	-	-	-	235.46
Debt / Equity Ratio	0.41	0.45	0.47	0.42	0.38	0.58
Debt / EBITDA Ratio	4.39	4.85	4.33	2.81	3.68	1.66
Debt / FCF Ratio	-	-	-	-	-	37.35
Asset Turnover	-	1.11	1.21	1.36	1.49	2.42
Inventory Turnover	-	4.12	4.28	4.12	4.08	4.92
Quick Ratio	0.43	0.41	0.81	0.47	1.18	0.59
Current Ratio	1.23	1.21	1.69	1.80	2.10	1.30
Return on Equity (ROE)	7.73%	7.08%	9.54%	12.75%	12.95%	29.05%
Return on Assets (ROA)	-	2.54%	3.75%	4.73%	3.60%	8.26%
Return on Capital (ROIC)	3.17%	3.09%	4.58%	5.88%	4.86%	13.30%
Return on Capital Employed (ROCE)	6.60%	6.60%	8.00%	11.30%	8.20%	30.90%
Earnings Yield	1.02%	0.92%	4.49%	9.27%	5.72%	8.18%
FCF Yield	-0.26%	-1.47%	-5.05%	-27.84%	-7.05%	0.48%
Dividend Yield	1.15%	-	-	-	2.40%	-
Payout Ratio	53.50%	111.73%	-	53.87%	29.96%	48.22%
Buyback Yield / Dilution	-	-62.83%	-	-	-	-
Total Shareholder Return	1.15%	-62.83%	-	-	2.40%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.